Canadian Journal of Infectious Diseases and Medical Microbiology / 2018 / Article / Tab 4 / Research Article
Isolation of Extended-Spectrum β -lactamase- (ESBL-) Producing Escherichia coli and Klebsiella pneumoniae from Patients with Community-Onset Urinary Tract Infections in Jimma University Specialized Hospital, Southwest Ethiopia Table 4 Resistance profiles of isolates from healthcare-associated versus true community-acquired in JUSH, Southwest of Ethiopia.
Antibiotics Total R (N %) Healthcare-associated Community-acquired valueR R S R S Cefotaxime 18 (24.3%) 9 (36%) 16 (64%) 9 (18.4%) 40 (81.6%) 0.168 Ceftriaxone 17 (23.0%) 9 (36%) 16 (64%) 9 (18.4%) 40 (81.6%) 0.168 Ceftazidime 16 (21.6%) 9 (36%) 16 (64%) 7 (14.3%) 42 (85.7%) 0.041 AMC 27 (36.5%) 10 (40%) 15 (60%) 17 (36.7%) 32 (65.3%) 0.799 Cephalothin 53 (71.6%) 18 (72%) 7 (28%) 35 (71.4%) 14 (28.6%) 1.000 Ampicillin 74 (100%) 25(100%) 0 49 (100%) 0 — Gentamicin 17 (23%) 9 (36%) 16 (64%) 8 (16.3%) 41(83.7%) 0.080 Amikacin 7 (9.5%) 4 (16%) 21 (84%) 3 (6.1%) 46 (93.9%) 0.217 NA 38 (51.4%) 14 (56%) 11 (44%) 24 (49%) 25 (51%) 0.628 CIP 24 (32.4%) 9 (36%) 16 (64%) 15 (30.6%) 34 (69.4%) 0.793 Norfloxacin 23 (31.1%) 9 (36%) 16 (64%) 14 (28.6%) 35 (71.4%) 0.793 SXT 41 (55.4%) 15 (60%) 10 (40%) 26 (53.1%) 23 (46.9%) 1.000 Tetracycline 45 (60.8%) 14 (56%) 11 (44%) 31 (54.4%) 18 (45.6%) 0.610 C 30 (40.5%) 14 (56%) 11 (44%) 16 (32.6%) 33 (67.4%) 0.079 Imipenem 0 0 25 (100%) 0 49 (100%) —
R: resistant, S: sensitive, AMC: amoxicillin-clavulanic acid, NA: nalidixic acid, CIP: ciprofloxacin, SXT: trimethoprim-sulfamethoxazole, C: chloramphenicol.